ETON
Eton Pharmaceuticals, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
40.80
close · 2026-08-13
value
5
cheaper than peers5
quality
62
stronger fundamentals62
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 18.72× | 28 |
| price to book | 36.46× | 16 |
| EV to EBITDA | 105.60× | 6 |
| price to sales | 14.70× | 5 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 40.4% | 89 |
| operating margin | 11.4% | 57 |
| debt to equity | 102.1% | 47 |
| return on equity | -5.4% | 34 |
4 of 4 measures available
Facts
| market cap | $1B |
| free cash flow | $2.4M |
| employees | 44 |
| first trade | 2018-11-13 |
| next earnings | 2026-08-13 |
| fundamentals updated | 2026-07-28 |